ReviewDiabetic medicine : a journal of the British Diabetic Association2022

Transitioning from basal-bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetes.

Roopa Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.